XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2
Condensed Consolidated Balance Sheet (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 6,987 $ 6,896
Short-term investments 232 383
Trade receivables, less allowances of $441 in 2024 and $444 in 2023 6,854 6,565
Inventories:    
Finished products 4,060 3,946
Work in process 880 807
Materials 1,874 1,817
Total inventories 6,814 6,570
Prepaid expenses and other receivables 2,232 2,256
Total Current Assets 23,119 22,670
Investments 877 799
Property and equipment, at cost 22,061 21,933
Less: accumulated depreciation and amortization 11,828 11,779
Net property and equipment 10,233 10,154
Intangible assets, net of amortization 7,827 8,815
Goodwill 23,308 23,679
Deferred income taxes and other assets 7,653 7,097
Total Assets 73,017 73,214
Current Liabilities:    
Trade accounts payable 4,125 4,295
Salaries, wages and commissions 1,389 1,597
Other accrued liabilities 5,071 5,422
Dividends payable 959 955
Income taxes payable 601 492
Current portion of long-term debt 1,615 1,080
Total Current Liabilities 13,760 13,841
Long-term debt 13,139 13,599
Post-employment obligations, deferred income taxes and other long-term liabilities 6,558 6,947
Commitments and Contingencies
Shareholders’ Investment:    
Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued 0 0
Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2024: 1,990,029,292; 2023: 1,987,883,852 24,858 24,869
Common shares held in treasury, at cost — Shares: 2024: 250,131,563; 2023: 253,807,494 (15,759) (15,981)
Earnings employed in the business 38,354 37,554
Accumulated other comprehensive income (loss) (8,135) (7,839)
Total Abbott Shareholders’ Investment 39,318 38,603
Noncontrolling Interests in Subsidiaries 242 224
Total Shareholders’ Investment 39,560 38,827
Total Liabilities and Shareholders' Investment $ 73,017 $ 73,214